The critical importance of basic animal research for neuropsychiatric disorders

Tracy L. Bale; Ted Abel; Huda Akil; William A. Carlezon; Bita Moghaddam; Eric J. Nestler; Kerry J. Ressler; Scott M. Thompson

doi:10.1038/s41386-019-0405-9

The critical importance of basic animal research for neuropsychiatric disorders

Tracy L. Bale, Ted Abel, Huda Akil, William A. Carlezon, Bita Moghaddam, Eric J. Nestler, Kerry J. Ressler, Scott M. Thompson

Research output: Contribution to journal › Article › peer-review

113 Scopus citations

Original language	English
Pages (from-to)	1349-1353
Number of pages	5
Journal	Neuropsychopharmacology
Volume	44
Issue number	8
DOIs	https://doi.org/10.1038/s41386-019-0405-9
State	Published - 1 Jul 2019

Access to Document

10.1038/s41386-019-0405-9

Cite this

@article{7b1d4d4ccff84a9582fb4a63c3929bcd,

title = "The critical importance of basic animal research for neuropsychiatric disorders",

author = "Bale, {Tracy L.} and Ted Abel and Huda Akil and Carlezon, {William A.} and Bita Moghaddam and Nestler, {Eric J.} and Ressler, {Kerry J.} and Thompson, {Scott M.}",

note = "Funding Information: Authors acknowledge support funding from NIMH grants: MH104184, MH108286, MH099910 (TLB); MH086828 (SMT); MH048404, MH115027 (BM), MH063266 (WAC), MH108665, MH110441, MH110925, MH117292 (KJR); MH051399, MH096890 (EJN), MH104261 (HA), MH087463, MH117964 (TA). In the past two years, Dr. Carlezon received payment as a consultant for Psy Therapeutics. The authors declare no competing interests.",

year = "2019",

month = jul,

day = "1",

doi = "10.1038/s41386-019-0405-9",

language = "English",

volume = "44",

pages = "1349--1353",

journal = "Neuropsychopharmacology",

issn = "0893-133X",

publisher = "Springer Nature",

number = "8",

}

TY - JOUR

T1 - The critical importance of basic animal research for neuropsychiatric disorders

AU - Bale, Tracy L.

AU - Abel, Ted

AU - Akil, Huda

AU - Carlezon, William A.

AU - Moghaddam, Bita

AU - Nestler, Eric J.

AU - Ressler, Kerry J.

AU - Thompson, Scott M.

N1 - Funding Information: Authors acknowledge support funding from NIMH grants: MH104184, MH108286, MH099910 (TLB); MH086828 (SMT); MH048404, MH115027 (BM), MH063266 (WAC), MH108665, MH110441, MH110925, MH117292 (KJR); MH051399, MH096890 (EJN), MH104261 (HA), MH087463, MH117964 (TA). In the past two years, Dr. Carlezon received payment as a consultant for Psy Therapeutics. The authors declare no competing interests.

PY - 2019/7/1

Y1 - 2019/7/1

UR - http://www.scopus.com/inward/record.url?scp=85065501355&partnerID=8YFLogxK

U2 - 10.1038/s41386-019-0405-9

DO - 10.1038/s41386-019-0405-9

M3 - Article

C2 - 31048727

AN - SCOPUS:85065501355

SN - 0893-133X

VL - 44

SP - 1349

EP - 1353

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

IS - 8

ER -